Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial.

Autor: Hurwitz LM; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Kulac I; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Pathology, Koç University School of Medicine, Istanbul, Turkey., Gumuskaya B; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Valle JABD; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Benedetti I; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Basic Sciences, School of Medicine, University of Cartagena, Cartagena, Colombia., Pan F; Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Liu JO; Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland., Marrone MT; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Arnold KB; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, Washington., Goodman PJ; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, Washington., Tangen CM; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, Washington., Lucia MS; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Thompson IM; CHRISTUS Santa Rosa Hospital Medical Center, San Antonio, Texas., Drake CG; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Isaacs WB; Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.; Department of Urology and the James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Nelson WG; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.; Department of Urology and the James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., De Marzo AM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.; Department of Urology and the James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Platz EA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. eplatz1@jhu.edu.; Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.; Department of Urology and the James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Publikováno v: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2020 Oct; Vol. 13 (10), pp. 853-862. Date of Electronic Publication: 2020 Jun 24.